---
title: "13:02 ETSalus Scientific Closes Oversubscribed Series A Financing, Raising $10.1 Million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294995541.md"
description: "Salus Scientific announced the successful closing of its oversubscribed Series A financing, raising $10.1 million against an initial target of $8.0 million. The round closed ahead of schedule due to strong investor demand. CEO Todd Flohr stated that the oversubscription endorses the company's commercial thesis and execution discipline. The raised capital will fund commercial scale-up, expand production and clinical infrastructure, and support revenue ramp-up."
datetime: "2026-08-05T17:03:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294995541.md)
  - [en](https://longbridge.com/en/news/294995541.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294995541.md)
generator: "portal-rs"
---

# 13:02 ETSalus Scientific Closes Oversubscribed Series A Financing, Raising $10.1 Million

, /PRNewswire/ -- Salus Scientific today announced the successful closing of its oversubscribed Series A financing, raising a total of **$10.1 million**. The company entered the round targeting $8.0 million, but investor demand proved substantially stronger, and the round closed above target and ahead of schedule.

The new capital gives Salus a durable runway to fund commercial scale-up, expand its production and clinical infrastructure, and carry the company through its revenue ramp.

"We are pleased to have closed our Series A above target and ahead of schedule," said **Todd Flohr, Chairman and Chief Executive Officer of Salus Scientific**. "We are thrilled to welcome partners who understand our value proposition and align with the company's long-term vision. That the round closed oversubscribed is, in our view, a direct endorsement of both our commercial thesis and our execution discipline."

**About Salus Scientific**  
Salus Scientific is building the occupational wellness platform for modern procedural medicine, redefining how healthcare organizations protect the physicians, technologists, and nurses who perform fluoroscopy-guided procedures.

**Media & Investor Contact**  
Keith Rosmarin  
Chief Financial Officer  
\[email protected\]

*Forward-Looking Statements: This press release contains "forward-looking statements," including statements regarding the company's use of proceeds, growth strategy, and future capital requirements. These statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially. The company undertakes no obligation to update forward-looking statements except as required by applicable law.*

SOURCE Salus Scientific

## Related News & Research

- [Blockchain Infrastructure Firm tZERO Integrates with Sui for Institutional-Grade Digital Asset Securities](https://longbridge.com/en/news/296922785.md)
- [REG - Sequoia Econ Infra - PDMR / PCA Shareholding](https://longbridge.com/en/news/296812006.md)
- [REG - RM Infrastructure RM SecDirect - RMDC - Holding(s) in Company](https://longbridge.com/en/news/296927465.md)
- [Infrastructure Dividend Split Corp declares August Class A distribution of $ 0.15 per share](https://longbridge.com/en/news/296799113.md)
- [EXM: Net profit increased on one-off gains, despite lower revenue and EBITDA year-over-year](https://longbridge.com/en/news/296991766.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**